DE
Stocks › United States › S&P 500 › AbbVie

AbbVie Stock Forecast & Price Target

Ticker ABBV ISIN US00287Y1091
289.92USD
−$2.10 (−0.72%)today
Real-time As of Nov 11, 2026, 9:04 AM ET
Quantum Forecast Range band

AbbVie Price Target 2026

The Quantum Forecast sees a price target of $295.13 (+1.8%) for AbbVie in about one month (by Dec 10, 2026).

Quantum Forecast price targets by time frame, calculated from the current price of $289.92. Click to see the forecast in the chart.

Time framePrice targetChangeRange band
1 monthby Dec 10, 2026 · Chart 6M$295.13 ▲ +1.8% $272.32 – $317.95
2 monthsby Jan 8, 2027 · Chart 1Y$282.29 ▼ −2.6% $250.94 – $313.64
6 monthsby May 12, 2027 · Chart 3Y$300.03 ▲ +3.5% $238.96 – $361.10
10 monthsby Sep 15, 2027 · Chart 5Y$282.71 ▼ −2.5% $205.66 – $359.75

AbbVie Forecast for Today and Tomorrow

In the short term, the Quantum Forecast sees AbbVie at $290.09 (+0.06%) today around 10:15 AM ET and at $290.40 (+0.17%) today around 3:30 PM ET. It is based on prices from the current trading day and the past week. Short-term forecast in the chart

AbbVie Stock 2026: Price Performance

AbbVie stock has gained 26.9% since the start of 2026 and currently trades at $289.92 (as of Nov 11, 2026). Over the same period the S&P 500 is up 10.9%, putting the stock 15.9 percentage points ahead of the index. Over the past 52 weeks the price ranged between $190.56 and $302.63; it is currently 4.2% below its high of Nov 5, 2026.

AbbVie Forecast 2027

Over a horizon of roughly 10 months (until about Sep 2027), the Quantum Forecast sees a price target of $282.71 for AbbVie – −2.5% from today. The range band runs from $205.66 – $359.75: the further ahead the forecast looks, the greater the uncertainty. See the long-term forecast in the chart

Community Forecast for AbbVie

There are no user forecasts for AbbVie yet – be the first to make one.

Make your own forecast

About AbbVie

AbbVie is a biopharmaceutical company headquartered in North Chicago, Illinois. It was spun off from Abbott Laboratories in 2013. The company develops and sells medicines in immunology, oncology, neuroscience and eye care, as well as aesthetic treatments. Key products include the immunology drugs Skyrizi and Rinvoq, the older blockbuster Humira, the cancer drugs Imbruvica and Venclexta, and neuroscience therapies such as Vraylar and migraine treatments. Through the 2020 acquisition of Allergan, AbbVie also owns Botox and other aesthetic products.

The U.S. is AbbVie's largest market. A central theme for the stock has been replacing revenue lost after Humira faced biosimilar competition, with Skyrizi and Rinvoq taking over as main growth drivers. Other factors include U.S. drug pricing policy, clinical trial results, acquisitions to strengthen the pipeline and demand for aesthetic treatments. AbbVie is known for its dividend. The stock trades on the New York Stock Exchange under the ticker ABBV and is part of the S&P 500.

The current price of AbbVie stock is $289.92 (−0.72% vs. the previous close). In today's trading the high was $293.43 and the low $289.46.

Index S&P 500Region United States Currency USD Price history since 2013

How the Quantum Forecast works

  1. Research from quantum physics. The models are the result of several years of research at the Max Planck Institute of Quantum Optics and LMU Munich and were transferred to the stock market.

  2. Spectra and correlations. Frequency spectra are calculated from current prices, and the relationships between price swings and volatility are analyzed. This produces the forecast and the risk assessment.

  3. Detecting herd behavior. Models of phase transitions from statistical physics describe when investors collectively fall into panic or euphoria – an early sign of possible crash situations.

  4. Swarm intelligence. User forecasts are checked once their time frame has expired and feed into the model, weighted by their hit rate.

The range band shows the typical fluctuation around the forecast. More on quantum physics & swarm intelligence

Frequently Asked Questions about AbbVie Stock

What is the AbbVie stock forecast?

The Quantum Forecast expects AbbVie to reach $295.13 in about one month (by Dec 10, 2026), a change of +1.8% from the current price of $289.92. Over roughly 10 months (by Sep 2027) the price target is $282.71 (−2.5%).

What is the AbbVie stock price target?

Quantum Forecast price targets by time frame: 1 month $295.13 (+1.8%), 2 months $282.29 (−2.6%), 6 months $300.03 (+3.5%), 10 months $282.71 (−2.5%). The range band shows the typical fluctuation around these targets.

Will AbbVie stock go up or down?

In the short term the Quantum Forecast points up (+1.8% over one month). No forecast is certain – it is based on historical prices and statistical analysis.

How is the Quantum Forecast computed?

Trends, frequency spectra and correlations are calculated from the price history using methods from quantum physics; user opinions are added as well (swarm intelligence). The range band reflects the volatility of the security and widens with the time horizon.

Can I make my own forecast for AbbVie?

Yes – in the Forecast League you pick long or short and a price target for 1 day up to 6 months. Forecasts are scored automatically when they expire; correct calls earn points and a spot on the leaderboard.

WelcomeSave your watchlist and forecasts across all your devices

My stuff

WatchlistSaved stocks Price alertssoon

Display

Sprache · Language

Deutsch